NYSE: HR · Real Estate · Ageing population

Healthcare Realty Trust Incorporated

Healthcare Realty is a REIT that owns or holds joint-venture stakes in 560 US outpatient medical buildings, 73% on or next to hospital campuses, leased to health systems and physician groups.

Our rating
Hold
12-month target
$17.38
Price, Nov 10, 2026
$19.35
Expected return, with dividend
−5%

Latest research: initiation, Nov 13, 2026Market value $6,646m

HRHoldTarget $17.38−5% expected
Our HR model 14 sheets: Summary, Thesis, Market Check, Assumptions, … · Updated Nov 22, 2026 Free to view Open the model
$19.35Price $17.3812-month target
Implied return -10% to our target. Bear to bull $14.13 to $19.73, from our initiation of Nov 13, 2026. We expect a total return of between −10% and +10% over the next 12 months.

Peer-anchored P/AFFO: a 12.52x rolled FY27E peer multiple on $1.37 of FY27E FAD gives a $17.15 base value. Bear, base and bull values of $14.13, $17.15 and $19.73 are weighted 30/50/20% to $16.76 and rolled 12 months at 3.71% (8.88% CAPM cost of equity less the 5.17% yield) to the $17.38 target. A private-market NAV of $21.68 (0.89x at the price) is a cross-check.

Bear case
$14.13
-27% from $19.35
  • Two Fed hikes, 10Y UST +50bp to 5.48%
  • FY27E same-store growth 3.0% on hospital margin squeeze
  • TI/LC 17.5% of NOI
  • FAD $1.29 a share at 10.9x
Base case
$17.15
-11% from $19.35
  • 10Y UST at 4.98%
  • Same-store NOI growth 4.5% fading to 3.25%
  • Re/development NOI $55.5m by FY29
  • FY27E FAD $1.37 a share at 12.5x
Bull case
$19.73
+2% from $19.35
  • 10Y UST −50bp to 4.48%
  • Cash spreads 6% to 8%, occupancy above 94%
  • FY27E same-store growth 5.5%
  • FY27E FAD $1.43 a share at 13.8x
Base P/AFFO value
$17.15
Probability-weighted value
$16.76
NAV cross-check
$21.68
Target P/AFFO (FY27E)
12.52x
P/AFFO FY27E at price
14.1x
P/FFO FY27E at price
11.0x
CAPM cost of equity
8.88%
12m upside to downside
0.24x

Our estimates

LineFY26EFY27EFY28E
EPS$1.67$1.75$1.82
Consensus$1.65$1.69—
Ours vs consensus+1.2%+3.6%—

Sign in to Penmark